NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - CUE BIOPHARMA INC ownership

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,150
-37.0%
5000.0%0.00%
Q2 2023$1,825
+82.5%
500
+614.3%
0.00%
Q4 2021$1,000700.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bleichroeder LP 755,028$1,736,5640.43%
Monaco Asset Management SAM 359,739$827,4000.24%
Slate Path Capital LP 2,402,455$5,525,6470.15%
SANDERS MORRIS HARRIS LLC 346,212$713,4260.15%
ADVISORY RESEARCH INC 257,225$591,6180.08%
Robertson Stephens Wealth Management, LLC 478,500$1,100,5500.07%
Annandale Capital, LLC 65,000$1500.04%
Good Life Advisors, LLC 112,000$257,6000.03%
CARLSON CAPITAL L P 135,000$310,5000.02%
CORNERCAP INVESTMENT COUNSEL INC 57,888$133,1420.02%
View complete list of CUE BIOPHARMA INC shareholders